EyePoint Pharmaceuticals
EYPT
#5228
Rank
โ‚น132.90 B
Marketcap
โ‚น1,605
Share price
0.45%
Change (1 day)
114.26%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น18.38 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has โ‚น18.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น31.81 B15.46%
2023-12-31โ‚น27.55 B130.38%
2022-12-31โ‚น11.96 B-24.03%
2021-12-31โ‚น15.74 B379.44%
2020-12-31โ‚น3.28 B107.33%
2019-12-31โ‚น1.58 B
2018-06-30โ‚น2.65 B143.05%
2017-06-30โ‚น1.09 B-44.2%
2016-06-30โ‚น1.95 B7.85%
2015-06-30โ‚น1.81 B65.54%
2014-06-30โ‚น1.09 B79.25%
2013-06-30โ‚น0.61 B-24.4%
2012-06-30โ‚น0.80 B-24.82%
2011-06-30โ‚น1.07 B31.99%
2010-06-30โ‚น0.81 B146.93%
2009-06-30โ‚น0.33 B-50.72%
2008-06-30โ‚น0.66 B519.05%
2007-06-30โ‚น0.10 B-79.64%
2006-06-30โ‚น0.53 B24.79%
2005-06-30โ‚น0.42 B-57.3%
2004-06-30โ‚น0.99 B2614.15%
2003-06-30โ‚น36.75 M
2001-06-30โ‚น77.25 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
โ‚น0.19 B-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚น11.89 M-99.94% Bahamas